Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis

This publication has 50 references indexed in Scilit:

• Predictors of Pathological Progression among Men with Localized Prostate Cancer Undergoing Active Surveillance: a Sub-Analysis of the REDEEM Study
  Journal of Urology, 2013
• Statin Use and Reduced Cancer-Related Mortality
  New England Journal of Medicine, 2012
• Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
  The Lancet, 2012
• Effect of treatment with 5‐α reductase inhibitors on progression in monitored men with favourable‐risk prostate cancer
  BJU International, 2012
• The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
  New England Journal of Medicine, 2011
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
  PLOS Medicine, 2009
• Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer
  BJU International, 2007
• Random-effects model for meta-analysis of clinical trials: An update
  Contemporary Clinical Trials, 2007
• Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation
  BJU International, 2006
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986